1. Home
  2. BCAB vs PRZO Comparison

BCAB vs PRZO Comparison

Compare BCAB & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • PRZO
  • Stock Information
  • Founded
  • BCAB 2007
  • PRZO 2014
  • Country
  • BCAB United States
  • PRZO Israel
  • Employees
  • BCAB N/A
  • PRZO N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • PRZO
  • Sector
  • BCAB Health Care
  • PRZO
  • Exchange
  • BCAB Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • BCAB 31.5M
  • PRZO 25.7M
  • IPO Year
  • BCAB 2020
  • PRZO 2023
  • Fundamental
  • Price
  • BCAB $0.68
  • PRZO $1.50
  • Analyst Decision
  • BCAB Hold
  • PRZO
  • Analyst Count
  • BCAB 3
  • PRZO 0
  • Target Price
  • BCAB $1.00
  • PRZO N/A
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • PRZO 811.2K
  • Earning Date
  • BCAB 11-06-2025
  • PRZO 08-28-2025
  • Dividend Yield
  • BCAB N/A
  • PRZO N/A
  • EPS Growth
  • BCAB N/A
  • PRZO N/A
  • EPS
  • BCAB N/A
  • PRZO N/A
  • Revenue
  • BCAB $11,000,000.00
  • PRZO $1,007,440.00
  • Revenue This Year
  • BCAB N/A
  • PRZO N/A
  • Revenue Next Year
  • BCAB N/A
  • PRZO N/A
  • P/E Ratio
  • BCAB N/A
  • PRZO N/A
  • Revenue Growth
  • BCAB N/A
  • PRZO 80.42
  • 52 Week Low
  • BCAB $0.24
  • PRZO $0.53
  • 52 Week High
  • BCAB $2.53
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 63.71
  • PRZO 54.75
  • Support Level
  • BCAB $0.60
  • PRZO $1.40
  • Resistance Level
  • BCAB $0.84
  • PRZO $1.58
  • Average True Range (ATR)
  • BCAB 0.08
  • PRZO 0.08
  • MACD
  • BCAB 0.02
  • PRZO 0.02
  • Stochastic Oscillator
  • BCAB 62.14
  • PRZO 75.76

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: